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Voiding Dysfunction
Clinical and Urodynamic Significance of Morphological Differences 
in Intravesical Prostatic Protrusion 
Seung Wook Lee, Jeong Man Cho, Jung Yoon Kang, Tag Keun Yoo
Department of Urology, Eulji Hospital, Eulji University School of Medicine, Seoul, Korea
Purpose: The objectives of this study were to evaluate whether morphologic differences 
correlated with urodynamic and clinical characteristics in patients with benign pro-
static hyperplasia (BPH) with intravesical prostatic protrusion (IPP) of trilobar or bilo-
bar adenoma.
Materials and Methods: Between January 2008 and June 2009, 72 male patients who 
had undergone transurethral resection (TUR) owing to BPH with IPP were included 
in this study. They underwent preoperative urodynamic studies, the International 
Prostate Symptom Score (IPSS)/quality of life (QoL), maximal flow rate (Qmax), post-
voiding residual urine volume (PVR), transrectal ultrasonography (TRUS), and serum 
prostate-specific antigen (PSA) measurement. The patients were classified into 2 
groups (the trilobar and bilobar adenoma groups) on the basis of video findings during 
the TUR operation.
Results: The trilobar and bilobar adenoma groups consisted of 37 patients and 35 pa-
tients, respectively. The Mean±SD IPP, prostate volume (PV), and transition zone vol-
ume of the trilobar and bilobar adenoma groups were 11.8±5.2 mm and 9.0±3.8 mm 
(p=0.014), 81.1±25.8 g and 59.3±22.5 g (p＜0.001), and 49.6±20.6 g and 34.8±19.4 g 
(p=0.003), respectively. The Mean±SD PSA, bladder contractility index (BCI), and 
bladder outlet obstruction index (BOOI) were 4.6±2.5 ng/ml and 3.5±1.7 ng/ml (p= 
0.042), 119.8±33.4 and 87.7±24.4 (p＜0.001), and 62.6±29.5 and 44.6±20.4 (p=0.005), 
respectively. There were no significant differences in IPSS/QoL, Qmax, PVR, acute uri-
nary retention, or detrusor overactivity in the 2 groups. 
Conclusions: IPP has two morphologic types of trilobar or bilobar enlargement. The PV, 
BOOI, and BCI were significantly smaller in the bilobar adenoma group than in the 
trilobar adenoma group. 
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INTRODUCTION
Benign prostatic enlargement is known to be the most com-
mon cause of bladder outlet obstruction (BOO) in male 
adults in their 50s or older [1,2]. The proper selection of pa-
tients is essential for adequate treatment in a clinical 
setting. Many tests have been proposed as the criteria for 
evaluation and selection of patients with prostatic enlarge-
ment, among which urodynamic tests are known to be the 
most helpful in the diagnosis of such patents [3,4]. However, 
these tests have some limitations in clinical application ow-
ing to their invasiveness and complications. Thus, a meth-
od for evaluating the degree of BOO by ultrasonography 
has been introduced. Since intravesical prostatic protru-
sion (IPP) assessed by ultrasonography has a significant 
correlation with the BOO index (BOOI), it is used as a po-
tent predictor of BOO [5]. Although IPP has been widely 
used as a predictor of BOO, morphological patterns of IPP 
have not yet been determined. Doo and Uh reported that 
there are significant differences in clinical parameters ac-Korean J Urol 2010;51:694-699
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cording to the structure of the prostate [6].
　IPP usually presents with 2 patterns at surgery: (1) the 
transition zone is enlarged and protrudes into the bladder, 
which is called bilobar adenoma, and (2) both the central 
and transition zones protrude into the bladder, which is 
called trilobar adenoma [6].
　Although IPP is usually found in a trilobar adenoma, 
where the median lobe of the prostate protrudes into the 
bladder, IPP with enlargement of the lateral lobe and no 
prominent median lobe is sometimes observed during tran-
surethral resection of the prostate (TURP). Therefore, this 
study was conducted to determine the prevalence of trilo-
bar and bilobar adenomas and to evaluate the relationship 
between morphological patterns and clinical and urody-
namic parameters.
MATERIALS AND METHODS
1. Study subjects
In this study, we retrospectively analyzed 72 patients with 
IPP confirmed by transrectal ultrasonography (TRUS) 
among 121 patients who underwent TURP between Janu-
ary 2008 and June 2009. The following patients were ex-
cluded from the study: (1) those with bladder cancers, (2) 
those with bladder stones, (3) those with neurogenic blad-
ders, and (4) those on medication with anticholinergics.
2. Methods
We investigated the correlations between morphological 
patterns of IPP and preoperative urodynamic test results, 
TRUS findings, International Prostate Symptom Score 
(IPSS), quality of life (QoL), and uroflowmetric results. We 
also investigated the correlations between morphological 
patterns of IPP and IPSS, QoL, and uroflowmetric results 
obtained 3 months after TURP. TRUS was performed with 
a 5 MHz transverse transducer and a 7.5 MHz longitudinal 
transducer by a urologist. The maximum transverse and 
longitudinal diameters of the prostate were measured, and 
prostate volume (PV) was calculated by the following for-
mula: PV = width x height x length x (π/6). The degree of 
IPP was defined as the shortest diameter between the blad-
der neck and the tip of the IPP on a sagittal image as de-
scribed by Mariappan et al [7]. It was divided into 3 grades: 
grade I, an IPP of ＜5 mm; grade II, an IPP of 5 to 10 mm; 
and grade III, an IPP of ＞10 mm (Fig. 1).
　The protrusion of the median and lateral lobes was eval-
uated through operative videotapes. By operative endos-
copy, bilobar adenoma was defined as a prominent lateral 
lobe with a kissing appearance without a prominent me-
dian lobe (the bilobar adenoma group), and trilobar ad-
enoma was defined as a prominent median lobe that cov-
ered more than half of the bladder neck (the trilobar ad-
enoma group) (Fig. 2). Adenomas with protrusion of a uni-
lateral lobe or a median lobe only were excluded. 
FIG. 1. The grading system for IPP. (A) Grade I (＜5 mm), (B) 
Grade II (5-10 mm), and (C) Grade III (＞10 mm) IPP. IPP: 
intravesical prostatic protrusion.Korean J Urol 2010;51:694-699
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FIG. 2. Anatomical differences in IPP
configuration between trilobar (A) 
and bilobar (B) adenomas. IPP: 
intravesical prostatic protrusion.
3. Statistical analysis
Statistical comparisons of preoperative IPSS, QoL, uroflo-
wmetric results, serum prostate-specific antigen (PSA), 
PV, transition zone volume (TZV), transition zone index 
(TZI), BOOI, and bladder contractility index (BCI) between 
the 2 groups were made with the independent t-test. 
Comparisons of preoperative acute urinary retention 
(AUR) and detrusor overactivity (DO) between the 2 groups 
were made with the chi-square test. The association be-
tween IPP and the aforementioned parameters was tested 
with the Pearson’s correlation coefficient and chi-square. 
All statistical analyses were performed by using the SPSS 
program version 12.0. A p-value of ＜0.05 was considered 
statistically significant. 
RESULTS
The mean age of the patients was 68.4±6.2 years. Mean se-
rum PSA was 4.1±2.2 ng/ml. Mean PV was 70.5±26.4 g, and 
mean TZV was 42.4±21.2 g. Mean TZI was 0.58±0.14 g. The 
mean weight of the prostate adenoma resected by TURP 
was 34.6±17.2 g. The mean length of IPP was 10.4±4.8 mm; 
grade I was observed in 9 patients (12.5%), grade II in 30 
patients (41.7%), and grade III in 33 patients (45.8%). 
　The trilobar group included 37 patients (51.4%), and the 
bilobar group included 35 patients (48.6%). There were no 
significant differences in preoperative IPSS, QoL, urine 
volume, maximal flow rate (Qmax), residual urine, TZI, or 
weight of the resected prostate adenoma between the 2 
groups. However, there were significant differences in IPP 
(11.8±5.2 mm vs. 9.0±3.8 mm, p=0.014), PV (81.1±25.8 g vs. 
59.3±22.5 g, p＜ 0.001), TZV (49.6±20.6 g vs. 34.8±19.4 g, 
p=0.003), BOOI (62.6±29.5 vs. 44.6±20.4, p=0.005), and 
BCI (119.8±33.4 vs. 87.1±24.4, p＜0.001) between the 2 
groups (Table 1). There were no significant differences in 
IPSS, QoL, urine volume, Qmax, or residual urine at the 
3-month follow-up between the 2 groups. 
　In the groups with grades I and II IPP, there were no sig-
nificant differences in the BOOI between the 2 groups. In 
the grade III group, however, the BOOI was significantly 
higher in the trilobar adenoma group than in the bilobar 
adenoma group (Table 1). In cases with a PV over 50 and 
under 80, PV and the BOOI were significantly higher in the 
trilobar adenoma group than in the bilobar adenoma group 
(Table 2, 3).
　AUR and DO were higher in the trilobar adenoma group 
than in the bilobar adenoma group, but the difference was 
not statistically significant (Table 1). In the trilobar aden-
oma group, IPP had a significant correlation with the BOOI 
(r=0.718, p＜0.001), whereas in the bilobar adenoma group, Korean J Urol 2010;51:694-699
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TABLE 1. Comparisons of the trilobar and bilobar adenoma 
groups
Variables
Trilobar 
adenoma group 
Bilobar 
adenoma group
p-value
No. of patients  37  35
IPSS total  20.3±8.6 20.1±6.9 0.93
QoL   4.0±1.4   4.7±0.9 0.17
Qmax (ml/sec)   8.6±3.6   8.8±4.6 0.79
PVR (ml)   61.5±60.0   40.1±67.0 0.18
TZI    0.59±0.14   0.55±0.13 0.2
IPP (mm) 11.8±5.2   9.0±3.8 0.014
a
PSA   4.6±2.5   3.5±1.7 0.042
a
PV (g)   81.1±25.8   59.3±22.5 ＜0.001
a
Less than 50     3  14
Over 50 under 80   16  14
80 or more  16    9
TZV (g)   49.6±20.6   34.8±19.4 0.003
a
BOOI    62.6±29.5   44.6±20.4 0.005
a
Grade I   40.3±19.3   31.7±12.6 0.46
Grade II 61.2±7.7   39.7±18.6 0.065
Grade III   82.6±21.6   54.8±20.9 0.023
a
BCI 119.8±33.4   87.7±24.4 ＜0.001
a
AUR (−)  27 (73%) 29 (82.9%)
0.29
AUR (＋) 10 (27%)   6 (17.1%)
DO (−)   21 (56.8%) 27 (77.1%)
0.056 DO (＋)    16 (43.2%)   8 (22.9%)
IPSS: International Prostate Symptom Score, QoL: quality of life,
Qmax: maximal flow rate, PVR: postvoid residual urine, TZI: tran-
sition zone index, IPP: intravesical prostatic protrusion, PSA: 
prostate-specific antigen, PV: prostate volume, TZV: transition 
zone volume, BOOI: bladder outlet obstruction index, BCI: blad-
der contractility index, AUR: acute urinary retention, DO: de-
trusor overactivity, 
a: p＜0.05
TABLE 2. Comparisons of the trilobar and bilobar adenoma 
groups (prostate volume over 50 and under 80)
Variables
Trilobar 
adenoma group 
Bilobar 
adenoma group
 p-value
No. of patients  16  14
IPSS total  19.6±9.5 20.8±7.9 0.74
QoL   4.0±1.3   4.1±1.0 0.85
Qmax (ml/sec)   9.0±4.2   9.8±5.5 0.68
PVR (ml)   53.5±52.9   38.7±49.6 0.48
TZI    0.62±0.13   0.56±0.11   0.272
IPP (mm) 11.5±5.0   9.2±3.4   0.174
PSA   5.6±3.7   4.2±1.7 0.18
PV (g) 66.9±8.4 60.3±7.9    0.037
a
TZV (g)   41.1±10.5   34.5±10.1   0.092
BOOI    72.9±32.3   39.8±18.4    0.003
a
BCI 127.8±30.9   80.4±27.6 < 0.001
a
IPSS: International Prostate Symptom Score, QoL: quality of life,
Qmax: maximal flow rate, PVR: postvoid residual urine, TZI: tran-
sition zone index, IPP: intravesical prostatic protrusion, PSA: 
prostate-specific antigen, PV: prostate volume, TZV: transition 
zone volume, BOOI: bladder outlet obstruction index, BCI: blad-
der contractility index, 
a: p＜0.05
TABLE 3. Comparisons of the trilobar and bilobar adenoma 
groups (prostate volume 80 or more)
Variables
Trilobar 
adenoma group 
Bilobar 
adenoma group
p-value
No. of patients  16   9
IPSS total  16.8±7.5 18.3±9.0 0.68
QoL   4.1±1.5   4.3±1.6 0.87
Qmax (ml/sec)   8.1±2.9   8.2±2.4 0.96
PVR (ml) 135.7±79.5 145.3±52.2 0.78
TZI 0.67±0.1 0.70±0.1 0.40
IPP (mm) 14.3±6.9 13.9±8.3 0.89
PSA   5.2±2.4   7.7±4.2 0.081
a
PV (g) 106.6±22.1   98.9±20.8 0.39
TZV (g)   71.5±18.0   67.6±16.0 0.59
BOOI    62.3±27.8   56.4±18.7 0.628
BCI 127.8±30.9 119.3±27.8 0.731
IPSS: International Prostate Symptom Score, QoL: quality of life,
Qmax: maximal flow rate, PVR: postvoid residual urine, TZI: tran-
sition zone index, IPP: intravesical prostatic protrusion, PSA: 
prostate-specific antigen, PV: prostate volume, TZV: transition 
zone volume, BOOI: bladder outlet obstruction index, BCI: blad-
der contractility index, 
a: p＜0.05
it had no significant correlation with the BOOI (r=0.265, 
p=0.136) (Fig. 3). 
　During hospitalization, blood transfusion was performed 
on 3 patients (8.1%) and 2 patients (5.7%) in the trilobar 
and bilobar adenoma groups, respectively. AUR due to 
blood clotting was observed in 7 patients (18.9%) and 4 pa-
tients (11.4%) in the trilobar and bilobar adenoma groups, 
respectively, whereas infection signs such as fever due to 
urinary tract infections were noted in 2 patients (5.4%) and 
2 patients (5.7%), respectively. These differences were not 
statistically significant.
DISCUSSION
Numerous studies have pointed out that BOO cannot be ac-
curately diagnosed on the basis of a single factor such as 
urinary symptoms, residual urine, or Qmax [8,9]. Ultraso-
nography has been widely used to examine the prostate ow-
ing to its safety and noninvasiveness. Chia et al reported 
that IPP assessed by ultrasonography is an excellent crite-
rion for predicting BOO [5]. Nose et al documented that the 
IPP grading system and Doppler urodynamic study have 
high sensitivities and specificities in the prediction of BOO 
[10]. Mariappan et al reported that when trial without 
catheter was performed on AUR patients 2 weeks after ad-
ministration of α-blockers, the degree of IPP was more po-
tent for the prediction of successful urination than was PV 
[7]. Although IPP has been widely applied because of its 
clinical usefulness, there have been few studies on the mor-
phological patterns and clinical implications of IPP.
　IPP is a morphological change by which the prostate pro-
trudes into the bladder during the process of prostatic 
enlargement. It is induced by the enlargement of the lateral Korean J Urol 2010;51:694-699
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FIG. 3. Scatter plot of the relationship between BOOI and IPP. 
(A) Scatter plot of the relationship between BOOI and IPP in the 
total patients (r=0.608, p＜0.001). (B) Scatter plot of the 
relationship between BOOI and IPP in the trilobar adenoma 
group (r=0.718, p＜0.001). (C) Scatter plot of the relationship 
between BOOI and IPP in the bilobar adenoma group (r=0.265, 
p=0.136). BOOI: bladder outlet obstruction index, IPP: intrave-
sical prostatic protrusion.
and median lobes, which leads to the ball-valve type of BOO 
and abnormal movement of the bladder due to the inhi-
bition of the funnel effect of the bladder neck at urination 
[11,12]. Chia et al have described that because strong blad-
der contraction opens the channel between the lateral lobes 
but accelerates the ball-valve effect by IPP, IPP induces 
more BOO than does the enlargement of the lateral lobe 
alone or prostatic enlargement without protrusion [5]. 
Early treatment including surgery is recommended for pa-
tients with IPP because IPP differs from dynamic ob-
struction by an increase in prostatic smooth muscle tone 
[13]. In this study, urodynamic tests showed that BOO was 
less severe in the bilobar adenoma group than in the trilo-
bar adenoma group. In addition, PV was smaller in the bilo-
bar adenoma group than in the trilobar adenoma group 
(81.1±25.8 g vs. 59.4±22.5 g, p＜0.001), but the mean BOOI 
was ＞40. These results imply that the ball-valve effect may 
exist in the bilobar adenoma group. It is conceivable that 
unilateral or bilateral lateral lobes that protruded to and 
floated in the bladder may have exerted the ball effect, un-
like in the trilobar adenoma group where the median lobe 
exerted the ball effect. It is also conceivable that in the bilo-
bar adenoma group, grade III IPP showed a greater BOOI 
than did grade I (54.8±20.9 vs. 31.7±12.6, p＜0.05).
　Because morphological patterns of IPP were difficult to 
discriminate between trilobar and bilobar adenomas, the 
AUC values of IPP, PV, and TZV were measured by ROC 
curve analysis. Among these 3 parameters, PV showed the 
highest AUC value (AUC, 0.737); PV showed the highest 
sensitivity and specificity when it was 64.5 g (sensitivity, 
80.6%; specificity, 60.0%). A number of patients with both 
grade III by TRUS and a PV of ＞60 g have the possibility 
of trilobar adenomas with apparently protruding median 
lobes, subsequently leading to severe BOO.
　The BCI was significantly lower in the bilobar adenoma 
group than in the trilobar adenoma group. BCI was meas-
ured by using the formula introduced by Abrams [3]: 
BCI=PdetQmax＋5Qmax
　Because at urination, BOO was more severe in the trilo-
bar adenoma group than in the bilobar adenoma group, 
bladder contractility was more elevated in order to over-
come the resistance, which subsequently led to an increase 
in PdetQmax. In contrast, it is thought that because the re-
sistance was smaller in the bilobar adenoma group, Pdet-
Qmax was decreased and BCI was lower. In this study, be-
cause patients with neurogenic bladders and those on med-
ication with anticholinergics were excluded from the ran-
domly selected study samples, considerable selection bias Korean J Urol 2010;51:694-699
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may have been avoided.
　Transabdominal ultrasonography has been used since 
the introduction of the concept of IPP. Mariappan et al used 
TRUS to measure the size of IPP and the prostate and con-
firmed that there was a significant correlation between IPP 
and BOO [7]. TRUS has some advantages over transabdo-
minal ultrasonography: (1) transabdominal ultrasonogra-
phy requires the bladder to be filled with 150 to 200 ml of 
normal saline, which may cause patient discomfort; (2) 
clinicians are more familiar with TRUS because TRUS is 
more frequently performed in a clinical setting than trans-
abdominal ultrasonography; and (3) IPP assessed by TRUS 
is able to excellently predict BOO in clinical practice. It has 
been reported that clinical parameters such as IPSS and 
QoL do not correlate with BOO [14], which is similar to our 
result.
　We acknowledge, however, the potential limitations of 
this study: (1) it is a retrospective study and (2) because 
there are no definite criteria for discrimination between 
trilobar and bilobar adenomas, there may have been bias 
in our results. However, despite the bias, this study pro-
vides the basis for understanding morphological patterns 
of IPP and urodynamic differences according to morpho-
logical changes in the prostate.
CONCLUSIONS
All IPPs assessed by TRUS did not represent trilobar ad-
enomas with apparent enlargement of the median lobe of 
the prostate. The results of this study confirm that the de-
gree of IPP, PV, BOOI, and BCI were significantly smaller 
in the bilobar adenoma group than in the trilobar adenoma 
group. More research with a prospective study design and 
a larger sample size is needed to establish definite criteria 
for determination of morphological patterns of IPP.
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